GlassScriptPhysician profile
Andrew Jervey Hunt
NPI 1750761094
$5,567.49
in general payments reported to CMS, 2019-2025
45 companies · $1,381 in 2025
The $1,381 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $214 · 2021: $359 · 2022: $441 · 2023: $976 · 2024: $1,845 · 2025: $1,381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,202.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $717.21 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $667.13 | 2021-2025 | |
| Novo Nordisk INC | $553.58 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $451.17 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $367.26 | 2019-2025 | Evenity, Prolia, Otezla |
| Pfizer INC. | $340.16 | 2019-2025 | |
| Glaxosmithkline, LLC. | $326.49 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Exact Sciences Corporation | $209.94 | 2023-2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $177.48 | 2024-2025 | Rexulti |
| Sanofi-Aventis U.S. LLC | $166.05 | 2022-2025 | |
| Inspire Medical Systems, INC. | $158.46 | 2023-2024 | Inspire |
| Painteq LLC | $157.06 | 2024 | Painteq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.08 | 2021-2025 | Jardiance |
| Medtronic, INC. | $115.51 | 2023-2025 | Intellis Adaptivestim, Inceptiv, Venaseal |
| Abbott Laboratories | $93.03 | 2021-2025 | Freestyle Libre 3, Proclaim, Eterna |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Hunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.